Loading...
Checkpoint inhibition and CAR T cells for the Treatment of Glioblastoma
INTRODUCTION: Glioblastoma (GBM) is a highly aggressive brain tumor and is one of the most lethal human cancers. Chimeric antigen receptor (CAR) T cell therapy has markedly improved survival in previously incurable disease; however, this vanguard treatment still faces challenges in GBM. Likewise, ch...
Saved in:
| Published in: | Expert Opin Biol Ther |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7202971/ https://ncbi.nlm.nih.gov/pubmed/32027536 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14712598.2020.1727436 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|